Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDA

BENZTROPINAMINE ANALOGS

  • Read more about BENZTROPINAMINE ANALOGS
US Application 60/689,746
Filed on 2005-06-10

Use Of Buprenorphine Adn Naloxone For Treating Alcoholism

  • Read more about Use Of Buprenorphine Adn Naloxone For Treating Alcoholism
US Application 60/319,988
Filed on 2003-03-03

Pyridomorphinans, Pyridazinomorphinans And Use Thereof

  • Read more about Pyridomorphinans, Pyridazinomorphinans And Use Thereof
US Application 60/497,901
Filed on 2003-08-27

Structurally Rigid Dopamine D3 Receptor Selective Ligands as Cocaine and Methamphetamine Abuse Therapeutics

  • Read more about Structurally Rigid Dopamine D3 Receptor Selective Ligands as Cocaine and Methamphetamine Abuse Therapeutics
US Application 60/410,715
Filed on 2002-09-14

Identification And Targeting of Consensus Sites By Which Dynorphin Exerts Its Neurotoxicity Effects Enables Analgesia Without...

  • Read more about Identification And Targeting of Consensus Sites By Which Dynorphin Exerts Its Neurotoxicity Effects Enables Analgesia Without...
US Application 60/459,830
Filed on 2003-04-01

Coil For Magnetic Stimulation and Methods For Using The Same

  • Read more about Coil For Magnetic Stimulation and Methods For Using The Same
US Application 60/242,297
Filed on 2000-10-20

TREATMENT OF SCHIZOPHRENIA, BIPOLAR DISORDER, AND CLUSTER SYNDROMES AS A NEURAL PLASTICITY DISORDER BY MODULATION OF N-CAM FRAGMENTS IN

  • Read more about TREATMENT OF SCHIZOPHRENIA, BIPOLAR DISORDER, AND CLUSTER SYNDROMES AS A NEURAL PLASTICITY DISORDER BY MODULATION OF N-CAM FRAGMENTS IN
US Application 60/177,971
Filed on 2000-01-25

cDNA Fragment T155c, From SV 40 Gene SV40 Large T, for Immortalizing Cells

  • Read more about cDNA Fragment T155c, From SV 40 Gene SV40 Large T, for Immortalizing Cells
US Application 60/136,492
Filed on 1999-05-28

SUBTAINED RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND ...

  • Read more about SUBTAINED RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND ...
US Application 60/030,248
Filed on 1996-10-31

4' AND 4',4 -SUBSTITUTED-3a-(DIPHENYLMETHOXY)TROPANE ANALOGS AS COCAINE THERAPEUTICS

  • Read more about 4' AND 4',4 -SUBSTITUTED-3a-(DIPHENYLMETHOXY)TROPANE ANALOGS AS COCAINE THERAPEUTICS
US Application 60/000,378
Filed on 1995-06-21

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDA
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health